Dr Zagnoni presented a talk on CAR-T efficacy using our Screenin3D platform at the Festival of Biologics

November 11th, 2021 Posted by Events, News, PR 0 thoughts on “Dr Zagnoni presented a talk on CAR-T efficacy using our Screenin3D platform at the Festival of Biologics”

Screenin3D microfluidic technology is a game-changing approach for pre-clinical drug and therapy testing. At the Festival of Biologics in Basel, Dr Zagnoni presented a talk on our bespoke Onco-Chip3D technology used for the screening of combination immunotherapies with CAR-Ts and their off-target cytotoxicity.

Leave a Reply

Our Company
Follow Us

 

© Copyright ScreenIn3D. All rights reserved 2019.
ScreenIn3D Limited registered in Scotland. Registered number SC614453
%d bloggers like this: